Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of ...
Source: benzinga.com
Page 16 - Processa Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Processa Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Processa Pharmaceuticals Today - Breaking & Trending Today
NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch
NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch KENILWORTH (NJ) (dpa-AFX) - Today's Daily Dose brings you news about Nektar's collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharma's strategic financing; and vTv Therapeutics' initiation of a phase 1 multiple ascending dose study of HPP737. Read on... 1. Nektar Teams Up With Merck Nektar Therapeutics (NKTR) has entered into a clinical trial collaboration and supply agreement with Merck (MRK) for a Phase 2/3 study of Bempegaldesleukin in combination with KEYTRUDA for firs...
Source: finanznachrichten.de
Mid-Afternoon Market Update: Dow Turns Positive; Luokung Technology Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 0.11% to 31,556.47 while the NASDAQ fell 0.89% to 13,921.94. The S&P also fell, dropping 0.27% to ...
Source: benzinga.com